[go: up one dir, main page]

MD4093B1 - Utilizare a compoziţiei farmaceutice topice cu conţinut de ambroxol - Google Patents

Utilizare a compoziţiei farmaceutice topice cu conţinut de ambroxol Download PDF

Info

Publication number
MD4093B1
MD4093B1 MDA20060268A MD20060268A MD4093B1 MD 4093 B1 MD4093 B1 MD 4093B1 MD A20060268 A MDA20060268 A MD A20060268A MD 20060268 A MD20060268 A MD 20060268A MD 4093 B1 MD4093 B1 MD 4093B1
Authority
MD
Moldova
Prior art keywords
topical pharmaceutical
pharmaceutical composition
composition containing
ambroxol
containing ambroxol
Prior art date
Application number
MDA20060268A
Other languages
English (en)
Russian (ru)
Inventor
Анке Эсперестер
Фридер Улрих МАЕРЦ
Клаудия МЮЛЛЕР
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966914&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD4093(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of MD4093B1 publication Critical patent/MD4093B1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la compoziţiile farmaceutice topice cu proprietăţi antiinflamatoare şi anestezice locale ce conţin ambroxol.Compoziţia, conform invenţiei, conţine de la 0,1 până la 20% ambroxol sau una din sărurile sale farmaceutic acceptabile, de preferinţă hidroclorură şi este destinată pentru tratamentul local al patologiilor pielii, cum sunt durerea, mâncărimea, usturimea, inflamaţia, înţepăturile de ţânţari şi hiperemia pielii de origine alergică, imunologică sau idiopată.
MDA20060268A 2004-05-03 2005-04-22 Utilizare a compoziţiei farmaceutice topice cu conţinut de ambroxol MD4093B1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004021992A DE102004021992A1 (de) 2004-05-03 2004-05-03 Topische Zubereitung enthaltend Ambroxol
PCT/EP2005/004343 WO2005107732A1 (de) 2004-05-03 2005-04-22 Topische zubereitung enthaltend ambroxol

Publications (1)

Publication Number Publication Date
MD4093B1 true MD4093B1 (ro) 2011-02-28

Family

ID=34966914

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060268A MD4093B1 (ro) 2004-05-03 2005-04-22 Utilizare a compoziţiei farmaceutice topice cu conţinut de ambroxol

Country Status (21)

Country Link
US (1) US20050266058A1 (ro)
EP (1) EP1744738A1 (ro)
JP (1) JP2007536296A (ro)
KR (1) KR20070005020A (ro)
CN (1) CN1950076A (ro)
AR (1) AR049036A1 (ro)
AU (1) AU2005239809A1 (ro)
BR (1) BRPI0510600A (ro)
CA (1) CA2565183A1 (ro)
DE (1) DE102004021992A1 (ro)
EC (1) ECSP066970A (ro)
IL (1) IL178975A0 (ro)
MD (1) MD4093B1 (ro)
MX (1) MXPA06012655A (ro)
PE (1) PE20060214A1 (ro)
RU (1) RU2381794C2 (ro)
SG (1) SG152257A1 (ro)
TW (1) TW200603787A (ro)
UA (1) UA87841C2 (ro)
WO (1) WO2005107732A1 (ro)
ZA (1) ZA200608017B (ro)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2493878C1 (ru) * 2009-09-18 2013-09-27 Дзе Проктер Энд Гэмбл Компани Основа, содержащая композицию в виде лосьона, ограничивающая прилипание фекалий или менструальных выделений к коже
WO2012069073A1 (de) * 2010-11-12 2012-05-31 La Prairie Group Ag Kosmetische und/oder dermatologische zubereitungen enthaltend schneealgenextrakt
EA201300535A1 (ru) * 2010-12-23 2013-08-30 Лектио Фармаэнтвиклунгс - Унд Фервертунгс Гмбх Водный раствор амброксола
UA112541C2 (uk) * 2011-03-14 2016-09-26 Бьорінгер Інгельхайм Інтернаціональ Гмбх Застосування гідрохлориду амброксолу для лікування гострого фарингіту
CA2830765C (en) * 2011-03-21 2019-02-05 Boehringer Ingelheim International Gmbh Solid preparation containing ambroxol
RU2513514C1 (ru) * 2012-11-23 2014-04-20 Общество с ограниченной ответственностью "НПК "Трифарма" Фармацевтическая композиция, содержащая налбуфина гидрохлорид, ее применение для лечения болевого синдрома средней и высокой интенсивности и способ получения фармацевтической композиции
JP6372559B2 (ja) * 2014-02-18 2018-08-15 大正製薬株式会社 内服液剤
CA2949882C (en) * 2014-05-23 2023-02-28 Boehringer Ingelheim International Gmbh Cough syrup containing ambroxol hydrochloride
CN109982692A (zh) 2016-11-14 2019-07-05 王明武 用于治疗眼表疾病的制剂和相关方法
WO2019018247A1 (en) 2017-07-16 2019-01-24 Neuere, Llc USE OF AMBROXOL TO IMPROVE AND / OR EXTEND THE LIFETIME IN GOOD HEALTH, LIFETIME AND / OR MENTAL ACUITY
JP7077582B2 (ja) * 2017-11-13 2022-05-31 京セラドキュメントソリューションズ株式会社 現像剤補給装置およびそれを備えた画像形成装置
CN111655223A (zh) * 2018-01-26 2020-09-11 努尔瑞有限责任公司 氨溴索改善皮肤屏障功能的用途
WO2020030991A1 (en) * 2018-08-09 2020-02-13 Nal Pharmaceutical Group Limited Dosage form for insertion into the mouth
CN113995721A (zh) * 2020-07-27 2022-02-01 德国吉麦医疗技术有限公司 一种盐酸氨溴索口腔喷雾溶液及其制备方法
CN112168783A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂及制备方法
CN112168782A (zh) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 一种呼吸系统药物口服喷雾剂的制备方法
EP4603084A1 (en) * 2022-11-14 2025-08-20 Shanghai Aurora Biotechnology Co., Ltd. Ambroxol oral dissolving film composition, preparation method therefor, and use thereof

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240907A2 (de) * 1986-04-02 1987-10-14 Krewel-Werke Gmbh Verwendung von trans-4-[(2-Amino-3,5-dibrom-benzyl)-amino]cyclohexanol
EP0546846A1 (en) * 1991-12-11 1993-06-16 Therapicon Srl Programmed-release pharmaceutical compositions
KR930011993B1 (ko) * 1991-12-23 1993-12-23 주식회사 럭키 지속성-방출형 약학적 조성물 및 그 제조방법
WO1995023591A1 (en) * 1994-03-03 1995-09-08 The Procter & Gamble Company Oral vehicle compositions
JPH10259130A (ja) * 1997-01-17 1998-09-29 Taisho Pharmaceut Co Ltd 経口投与用製剤
JP2000007561A (ja) * 1998-06-18 2000-01-11 Nissho Corp 塩酸アンブロキソール水溶液製剤
BG103806A (en) * 1997-03-18 2000-04-28 Miles GALIN Controlled release of pharmaceutical preparations in the front eye chamber
WO2000038653A1 (en) * 1998-12-23 2000-07-06 Idea Ag. Improved formulation for topical non-invasive application in vivo
KR20030045473A (ko) * 2001-12-04 2003-06-11 대신제약주식회사 점막부착성을 가지는 의약품 조성물
WO2003061642A1 (de) * 2002-01-25 2003-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Verwendung von ambroxol zur behandlung von chronischen schmerzen, cerebralen exzitotoxizitätsbedingten störungen und kardialen arrhythmien
EP1200070B1 (de) * 1999-07-20 2003-08-06 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Ambroxolhaltige lutschtablette
WO2003072094A1 (de) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co Kg Ambroxol für die behandlung von schmerzhaften zuständen im mund und rachenraum
CN1546008A (zh) * 2003-12-02 2004-11-17 沈阳药科大学 盐酸氨溴索液体缓释制剂及其制备方法
CN1602848A (zh) * 2004-08-23 2005-04-06 南昌弘益科技有限公司 盐酸氨索溴滴丸及其制备方法
CN1628645A (zh) * 2003-12-15 2005-06-22 南京金鹰医药科技开发有限公司 盐酸氨溴索口腔崩解片及其制备方法
CN1634004A (zh) * 2004-10-01 2005-07-06 耿燕 盐酸氨溴索滴丸及其制备方法
CN1650868A (zh) * 2004-12-02 2005-08-10 四川川投医药生物技术有限责任公司 一种治疗肺部感染性疾病的复方药物制剂及其制备方法
CN1820755A (zh) * 2006-04-03 2006-08-23 陈旭良 头孢呋辛/盐酸氨溴索的药物组合
CN1839802A (zh) * 2006-01-27 2006-10-04 无锡山禾药业股份有限公司 一种盐酸氨溴索口腔崩解片及其制备方法
CN1843372A (zh) * 2006-05-11 2006-10-11 陈旭良 氨溴索与两种抗菌药物分别组成的药物组合
CN101084912A (zh) * 2007-07-02 2007-12-12 山东省医药工业研究所 复方盐酸氨溴索缓释片及其制备方法
CN101099730A (zh) * 2006-07-03 2008-01-09 天津康鸿医药科技发展有限公司 含盐酸氨溴索与愈创木酚甘油醚活性成分的口服固体制剂
CN101352417A (zh) * 2008-08-29 2009-01-28 扬州市三药制药有限公司 盐酸氨溴索口服溶液及其制备方法
JP2009019052A (ja) * 1997-01-17 2009-01-29 Taisho Pharmaceutical Co Ltd 経口投与用製剤
JP2009137933A (ja) * 2007-09-17 2009-06-25 Hospital For Sick Children ゴーシェ病の治療方法
CN101480382A (zh) * 2008-01-09 2009-07-15 大百汇生物科技（深圳）有限公司 一种治疗急慢性鼻窦炎的药物组合物及其制备方法
JP2009235093A (ja) * 2001-12-21 2009-10-15 Daiichi Sankyo Healthcare Co Ltd 鼻炎用医薬組成物
CN101590043A (zh) * 2009-07-03 2009-12-02 北京华禧联合科技发展有限公司 一种治疗呼吸道感染的复方制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
US20030216423A1 (en) * 2000-05-24 2003-11-20 Sergio Ulloa Stable liquid and solid formulations
US20030171391A1 (en) * 2002-01-25 2003-09-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of chronic pain
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
DE10332487A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
DE10332473A1 (de) * 2003-07-16 2005-02-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von Epilepsie

Patent Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240907A2 (de) * 1986-04-02 1987-10-14 Krewel-Werke Gmbh Verwendung von trans-4-[(2-Amino-3,5-dibrom-benzyl)-amino]cyclohexanol
EP0546846A1 (en) * 1991-12-11 1993-06-16 Therapicon Srl Programmed-release pharmaceutical compositions
KR930011993B1 (ko) * 1991-12-23 1993-12-23 주식회사 럭키 지속성-방출형 약학적 조성물 및 그 제조방법
WO1995023591A1 (en) * 1994-03-03 1995-09-08 The Procter & Gamble Company Oral vehicle compositions
JP2009019052A (ja) * 1997-01-17 2009-01-29 Taisho Pharmaceutical Co Ltd 経口投与用製剤
JPH10259130A (ja) * 1997-01-17 1998-09-29 Taisho Pharmaceut Co Ltd 経口投与用製剤
BG103806A (en) * 1997-03-18 2000-04-28 Miles GALIN Controlled release of pharmaceutical preparations in the front eye chamber
JP2000007561A (ja) * 1998-06-18 2000-01-11 Nissho Corp 塩酸アンブロキソール水溶液製剤
WO2000038653A1 (en) * 1998-12-23 2000-07-06 Idea Ag. Improved formulation for topical non-invasive application in vivo
EP1352646A2 (de) * 1999-07-20 2003-10-15 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Ambroxolhaltige Lutschtablette
EP1200070B1 (de) * 1999-07-20 2003-08-06 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Ambroxolhaltige lutschtablette
KR20030045473A (ko) * 2001-12-04 2003-06-11 대신제약주식회사 점막부착성을 가지는 의약품 조성물
JP2009235093A (ja) * 2001-12-21 2009-10-15 Daiichi Sankyo Healthcare Co Ltd 鼻炎用医薬組成物
WO2003061642A1 (de) * 2002-01-25 2003-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Verwendung von ambroxol zur behandlung von chronischen schmerzen, cerebralen exzitotoxizitätsbedingten störungen und kardialen arrhythmien
WO2003072094A1 (de) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co Kg Ambroxol für die behandlung von schmerzhaften zuständen im mund und rachenraum
CN1546008A (zh) * 2003-12-02 2004-11-17 沈阳药科大学 盐酸氨溴索液体缓释制剂及其制备方法
CN1628645A (zh) * 2003-12-15 2005-06-22 南京金鹰医药科技开发有限公司 盐酸氨溴索口腔崩解片及其制备方法
CN1602848A (zh) * 2004-08-23 2005-04-06 南昌弘益科技有限公司 盐酸氨索溴滴丸及其制备方法
CN1634004A (zh) * 2004-10-01 2005-07-06 耿燕 盐酸氨溴索滴丸及其制备方法
CN1650868A (zh) * 2004-12-02 2005-08-10 四川川投医药生物技术有限责任公司 一种治疗肺部感染性疾病的复方药物制剂及其制备方法
CN1839802A (zh) * 2006-01-27 2006-10-04 无锡山禾药业股份有限公司 一种盐酸氨溴索口腔崩解片及其制备方法
CN1820755A (zh) * 2006-04-03 2006-08-23 陈旭良 头孢呋辛/盐酸氨溴索的药物组合
CN1843372A (zh) * 2006-05-11 2006-10-11 陈旭良 氨溴索与两种抗菌药物分别组成的药物组合
CN101099730A (zh) * 2006-07-03 2008-01-09 天津康鸿医药科技发展有限公司 含盐酸氨溴索与愈创木酚甘油醚活性成分的口服固体制剂
CN101084912A (zh) * 2007-07-02 2007-12-12 山东省医药工业研究所 复方盐酸氨溴索缓释片及其制备方法
JP2009137933A (ja) * 2007-09-17 2009-06-25 Hospital For Sick Children ゴーシェ病の治療方法
CN101480382A (zh) * 2008-01-09 2009-07-15 大百汇生物科技（深圳）有限公司 一种治疗急慢性鼻窦炎的药物组合物及其制备方法
CN101352417A (zh) * 2008-08-29 2009-01-28 扬州市三药制药有限公司 盐酸氨溴索口服溶液及其制备方法
CN101590043A (zh) * 2009-07-03 2009-12-02 北京华禧联合科技发展有限公司 一种治疗呼吸道感染的复方制剂及其制备方法

Also Published As

Publication number Publication date
DE102004021992A1 (de) 2005-11-24
RU2381794C2 (ru) 2010-02-20
RU2006142735A (ru) 2008-06-20
MXPA06012655A (es) 2007-01-16
KR20070005020A (ko) 2007-01-09
BRPI0510600A (pt) 2007-10-30
WO2005107732A1 (de) 2005-11-17
UA87841C2 (ru) 2009-08-25
AU2005239809A1 (en) 2005-11-17
CN1950076A (zh) 2007-04-18
PE20060214A1 (es) 2006-04-26
IL178975A0 (en) 2007-03-08
ZA200608017B (en) 2008-07-30
EP1744738A1 (de) 2007-01-24
ECSP066970A (es) 2006-12-29
CA2565183A1 (en) 2005-11-17
TW200603787A (en) 2006-02-01
AR049036A1 (es) 2006-06-21
JP2007536296A (ja) 2007-12-13
US20050266058A1 (en) 2005-12-01
SG152257A1 (en) 2009-05-29

Similar Documents

Publication Publication Date Title
MD4093B1 (ro) Utilizare a compoziţiei farmaceutice topice cu conţinut de ambroxol
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
ATE530544T1 (de) Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren
CL2007002169A1 (es) Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
EA200802020A1 (ru) Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1
RU2009120990A (ru) Применение тестостерона и агониста 5-нт1а для лечения сексуальной дисфункции
DE69930259D1 (de) Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
ATE475650T1 (de) Positive allosterische chinolon-m1- rezeptormodulatoren
BRPI0519124A2 (pt) composto, mÉtodo para tratar, prevenir ou melhorar obesidade e doenÇas relacionadas e/ou sintomas das mesmas, composiÇço farmacÊutica, uso de composto, e, combinaÇço
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
UA86970C2 (en) Morpholine compounds
DE602005018758D1 (de) Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
DE602004011394D1 (en) Thiazolderivate
EA201071039A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
WO2007143557A3 (en) Compounds and methods for treating mammalian gastrointestinal parasitic infections
BR0214497A (pt) Composição farmacêutica que compreende um agonista do receptor 5ht1
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
CY1111588T1 (el) Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι
EA200800783A1 (ru) Композиция тразодона для введения один раз в день
WO2010010394A3 (en) Local pharmaceutical compositions comprising an extract of spilanthes
EA200601510A1 (ru) Производные фенилэтаноламина в качестве бета-2-агонистов
EP1633323A4 (en) TERNARY AND QUATERARY EUTEKTICAL MIXTURES
MD2492F1 (ro) Remediu cu actiune antiinflamatoare, de cicatrizare si regeneratoare

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)